Song Y. Park, MD
My grandfather was diagnosed with a rare type of metastatic cancer during my residency. He received treatment at the hospital where I was training, which allowed me to help coordinate his care. I realized how difficult it can be to navigate treatment if you don’t have a medical background. I also learned how effective multidisciplinary care — a team approach to medicine — can improve a patient’s experience. One of the things that drew me to SCCA is its strong culture of collaboration across specialties. I am excited to be a part of this extraordinary care team.
Conversations about medical problems like cancer can be complicated and hard to follow, particularly if you are feeling the stress of a new diagnosis and pressing treatment decisions must be made. I also realize that people differ in how much information they want to know and how they want to interact with the care team. My goal is to customize our discussions according to your preferences, holding space for your concerns. I also welcome your questions. They prompt discussion and motivate me to carry out research and to find necessary answers. It is a great joy to bring the right information to the right patient.
I am a board-certified dermatologist from South Korea. Before I joined SCCA as a physician, I worked as a clinical research fellow with Dr. Paul Nghiem. In this role, I coordinated patient care and participated in research on Merkel cell carcinoma (MCC), a rare type of skin cancer.
Now, I specialize in treating patients with various skin cancers, including MCC and melanoma. I also work with people who are experiencing skin problems associated with cancer treatment. One primary area of interest is treating patients with intralesional therapy, where concentrated doses of a medication are injected directly into a skin lesion. The benefit of this type of therapy is that it allows us to treat a problem locally, minimizing side effects to the rest of the body.
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
Your care team
SCCA accepts most national private health insurance plans as well as Medicare. We also accept Medicaid for people from Washington, Alaska, Montana and Idaho. We are working to ensure that everyone, no matter what their financial situation, has access to the care they need.